[
  {
    "date": "2022-12-30",
    "symbol": "ACHV",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "tradingsymbol": "ACHV",
    "entityincorporationstatecountrycode": "Delaware",
    "entityregistrantname": "Achieve Life Sciences, Inc.",
    "entitycentralindexkey": 949858,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "033-80623",
    "entitytaxidentificationnumber": "95-4343413",
    "entityaddressaddressline1": "1040 West Georgia Street",
    "entityaddressaddressline2": "Suite 1030",
    "entityaddresscityortown": "Vancouver",
    "entityaddressstateorprovince": "BC",
    "entityaddresspostalzipcode": "V6E 4H1",
    "cityareacode": 604,
    "localphonenumber": "210-2217",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "Nasdaq",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 271,
    "auditorname": "PricewaterhouseCooopers LLP",
    "auditorlocation": "Vancouver, BC, Canada",
    "cashandcashequivalentsatcarryingvalue": 24771000,
    "grantsreceivablecurrent": 100000,
    "prepaidexpenseandotherassetscurrent": 2454000,
    "assetscurrent": 27330000,
    "restrictedcashandotherassets": 66000,
    "operatingleaserightofuseasset": 123000,
    "finitelivedintangibleassetsnet": 1418000,
    "goodwill": 1034000,
    "assets": 29971000,
    "accountspayablecurrent": 1660000,
    "otheraccruedliabilitiescurrent": 403000,
    "accruedliabilitiesclinicalcurrent": 1729000,
    "employeerelatedliabilitiescurrent": 1678000,
    "operatingleaseliabilitycurrent": 58000,
    "convertibledebtcurrent": 16071000,
    "liabilitiescurrent": 21599000,
    "operatingleaseliabilitynoncurrent": 69000,
    "liabilities": 21668000,
    "commonstockvalue": 87000,
    "additionalpaidincapitalcommonstock": 144148000,
    "retainedearningsaccumulateddeficit": -135936000,
    "accumulatedothercomprehensiveincomelossnetoftax": 4000,
    "stockholdersequity": -135936000,
    "liabilitiesandstockholdersequity": 29971000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesdesignated": 6256,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 30078000,
    "generalandadministrativeexpense": 10722000,
    "costsandexpenses": 40800000,
    "investmentincomeinterest": 199000,
    "interestexpense": 1789000,
    "othernonoperatingincomeexpense": 40000,
    "nonoperatingincomeexpense": -1550000,
    "netincomeloss": -42350000,
    "earningspersharebasic": -4,
    "earningspersharediluted": -4,
    "weightedaveragenumberofsharesoutstandingbasic": "null",
    "weightedaveragenumberofdilutedsharesoutstanding": "null",
    "sharesissued": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 3270000,
    "sharesissuedonexerciseofwarrantsvalue": 24000,
    "sharesissuedonexerciseofwarrants": 3709,
    "adjustmentstoadditionalpaidincapitalsharesissuedthroughatthemarketoffering": 1330000,
    "adjustmentstoadditionalpaidincapitalsharesissuedthroughatthemarketofferingshares": 200000,
    "stockissuedduringperiodvaluenewissues": 17882000,
    "stockissuedduringperiodsharesnewissues": 200000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 26625,
    "stockissuedduringperiodvaluerestrictedstockunitsettlementwithheldandretiredtotreasury": -47000,
    "stockissuedduringperiodsharesrestrictedstockunitsettlementwithheldandretiredtotreasury": -5605,
    "stockissuedduringperiodvalueemployeestockpurchaseplan": 126000,
    "stockissuedduringperiodsharesemployeestockpurchaseplans": 28892,
    "profitloss": -42350000,
    "depreciationandamortization": 236000,
    "sharebasedcompensation": 2153000,
    "sharesissuedassettlementwithtradevendorasnonmonetarytransaction": 26000,
    "accruedinterestonsvbconvertibledebt": -1170000,
    "increasedecreaseingrantsreceivable": -48000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 931000,
    "increasedecreaseinaccountspayabletrade": 819000,
    "increasedecreaseinotheraccruedliabilities": 55000,
    "increasedecreaseinaccruedclinicalliabilities": 376000,
    "increasedecreaseinemployeerelatedliabilities": -263000,
    "increasedecreaseinleaseobligations": 5000,
    "netcashprovidedbyusedinoperatingactivities": -37549000,
    "proceedsfromwarrantexercises": 24480,
    "proceedsfromissuanceofprivateplacement": 17882000,
    "paymentsoffinancingcosts": 20000,
    "proceedsfromatmarketoffering": 1330000,
    "proceedsfromstockplans": 126000,
    "paymentsrelatedtotaxwithholdingforsharebasedcompensation": 47000,
    "netcashprovidedbyusedinfinancingactivities": 19295000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 3000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -18251000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 24821000,
    "workingcapitalbalance": 5700000,
    "lineofcreditfacilitycurrentborrowingcapacity": 10000000,
    "maturityperiodofhighlyliquidinvestmentstobeconsideredascashequivalent": "three months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "three years",
    "numberofoperatingsegments": 1,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2019",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "propertyplantandequipmentusefullife": "10 years",
    "propertyplantandequipmentestimatedusefullives": "Over the term of the lease",
    "cash": 1800000,
    "cashequivalentsatcarryingvalue": 22756000,
    "maturityperiodofsecurities": "one year",
    "averageperiodtomaturityforportfolioofcashandmarketablesecurities": "P0D",
    "grantawarded": 2800000,
    "researchanddevelopmentexpensesincreasedecrease": -1300000,
    "amortizationofintangibleassets": 200000,
    "finitelivedintangibleassetsgross": 3117000,
    "finitelivedintangibleassetsaccumulatedamortization": 1699000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 223000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 223000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 526000,
    "maximummaturityperiodofcashandcashequivalents": 90,
    "assetsfairvaluedisclosure": 22806000,
    "restrictedcashandcashequivalents": 50000,
    "debtinstrumentfaceamount": 15000000,
    "convertibledebt": 16071000,
    "convertibledebtfairvaluedisclosures": 16987000,
    "propertyplantandequipmentgross": 303000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 299000,
    "propertyplantandequipmentnet": 4000,
    "deferredfinancecostsnet": 67000,
    "interestpayablecurrentandnoncurrent": 1138000,
    "futureincometaxrateassumedfordeferredtaxcalculations": 0.21,
    "deferredtaxassetsliabilitiesvaluationallowance": 64900000.00000001,
    "valuationallowancedeferredtaxassetchangeinamount": 10400000,
    "operatinglosscarryforwards": 3400000,
    "operatinglosscarryforwardsexpirationyear": 2022,
    "operatinglosscarryforwardsindefinitely": 55900000,
    "taxcreditcarryforwardamount": 2700000,
    "taxcreditcarryforwardexpirationyear": 2042,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "noncapitalgainlosscarryforwardsamount": 110000000,
    "unclaimedtaxdeductionsrelatedtoscientificresearchandexperimentaldevelopmentexpenditures": 15800000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 800000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -41660000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -690000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -42350000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -8894000,
    "incometaxreconciliationnondeductibleexpense": 299000,
    "incometaxreconciliationchangeinenactedtaxrate": -18000,
    "incometaxreconciliationforeignincometaxratedifferential": -26000,
    "incometaxreconciliationtaxcreditsresearchanddevelopment": 1154000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 10464000,
    "incometaxreconciliationreassessmentofpreviouslyrecognizednetoperatinglosses": 9000,
    "incometaxreconciliationadjustmenttoprioryearresearchanddevelopmenttaxcredits": 731000,
    "incometaxreconciliationotheradjustments": 51000,
    "deferredtaxassetspropertyplantandequipment": 899000,
    "deferredtaxassetsoperatinglosscarryforwards": 43380000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 8942000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1042000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 11342000,
    "deferredtaxassetsother": 334000,
    "deferredtaxassetsgross": 65939000,
    "deferredtaxassetsvaluationallowance": 65546000,
    "deferredtaxassetsnet": 393000,
    "deferredtaxliabilitiesother": 393000,
    "deferredincometaxliabilities": 393000,
    "unrecognizedtaxbenefits": 761000,
    "opentaxyear": 2022,
    "preferredstocksharesauthorized": "null",
    "saleofstockdescriptionoftransaction": "Unit consisting of (a) one share of our common stock and (b) one warrant to purchase one-quarter of a share of common stock at an exercise price of $699.20 per share, or LPC Warrant.  Each LPC Warrant became exercisable six months following the issuance date until the date that is five years and six months after the issuance date and is subject to customary adjustments.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 6.6,
    "proceedsfromissuanceofcommonstockgross": 1500000,
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 3709,
    "commonstocksharesavailableforfuturegrant": 23500000,
    "stockunitsdescription": "each unit consisting of two shares of common stock and a common stock purchase warrant to purchase one share of common stock, or the November 2022 Warrants",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 204,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 822515,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 252875,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 300450,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.79,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 3200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 0.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0165,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 5.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.228,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 18.57,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.83,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 28522.56,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 59.31,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 28952,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 822515,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 18.57,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P8Y2M15D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 300550,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 34.44,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P7Y6M3D",
    "allocatedsharebasedcompensationexpense": 1100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 1200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 252875,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 226250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 26625,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 8.77,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.26,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 13.09,
    "sharebasedcompensationmaximumnumberofsharesauthorizedtopurchased": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardsharespurchasedforaward": 28892,
    "classofwarrantorrightoutstanding": "null",
    "classofwarrantorrightnewexercisepriceofwarrantsorrights": 2.31,
    "classofwarrantsorrightexpirationdate": "November 2029",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6400000,
    "contractualobligation": 138000,
    "contractualobligationdueinnexttwelvemonths": 66000,
    "contractualobligationdueinsecondandthirdyear": 72000,
    "lesseeoperatingleasedescription": "On December 11, 2017, we entered into a lease, or the Seattle Lease, with 520 Pike Street, Inc., or Pike, pursuant to which we leased approximately 3,187 square feet located at Suite 2250 at 520 Pike Tower, Seattle, Washington, 98101, which commenced on March 1, 2018. The Seattle Lease expired on March 1, 2021 and was not renewed.",
    "operatingleaseexpense": 100000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 66000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 66000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6000,
    "lesseeoperatingleaseliabilitypaymentsdue": 138000,
    "operatingleasepayments": 59000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 120000,
    "operatingleaseweightedaverageremainingleaseterm1": 2.08,
    "operatingleaseweightedaveragediscountratepercent": 0.0898
  },
  {
    "date": "2021-12-30",
    "symbol": "ACHV",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "tradingsymbol": "ACHV",
    "entityincorporationstatecountrycode": "Delaware",
    "entityregistrantname": "Achieve Life Sciences, Inc.",
    "entitycentralindexkey": 949858,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "033-80623",
    "entitytaxidentificationnumber": "95-4343413",
    "entityaddressaddressline1": "1040 West Georgia Street",
    "entityaddressaddressline2": "Suite 1030",
    "entityaddresscityortown": "Vancouver",
    "entityaddressstateorprovince": "BC",
    "entityaddresspostalzipcode": "V6E 4H1",
    "cityareacode": 604,
    "localphonenumber": "210-2217",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "icfrauditorattestationflag": "false",
    "auditorfirmid": 271,
    "auditorname": "PricewaterhouseCooopers LLP",
    "auditorlocation": "Vancouver, BC, Canada",
    "cashandcashequivalentsatcarryingvalue": 43022000,
    "grantsreceivablecurrent": 200000,
    "prepaidexpenseandotherassetscurrent": 1419000,
    "assetscurrent": 44594000,
    "otherassetsandrestrictedcash": 183000,
    "operatingleaserightofuseasset": 64000,
    "finitelivedintangibleassetsnet": 1641000,
    "goodwill": 1034000,
    "assets": 47516000,
    "accountspayablecurrent": 841000,
    "otheraccruedliabilitiescurrent": 348000,
    "accruedliabilitiesclinicalcurrent": 1352000,
    "employeerelatedliabilitiescurrent": 1940000,
    "operatingleaseliabilitycurrent": 69000,
    "liabilitiescurrent": 4550000,
    "convertibledebtnoncurrent": 14920000,
    "operatingleaseliabilitynoncurrent": 4000,
    "liabilities": 19474000,
    "commonstockvalue": 79000,
    "additionalpaidincapitalcommonstock": 121545000,
    "retainedearningsaccumulateddeficit": -93586000,
    "accumulatedothercomprehensiveincomelossnetoftax": 4000,
    "stockholdersequity": -93586000,
    "liabilitiesandstockholdersequity": 47516000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesdesignated": 6256,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "researchanddevelopmentexpense": 23966000,
    "generalandadministrativeexpense": 9128000,
    "costsandexpenses": 33094000,
    "investmentincomeinterest": 17000,
    "othernonoperatingincomeexpense": -75000,
    "nonoperatingincomeexpense": -58000,
    "netincomeloss": -33152000,
    "earningspersharebasicanddiluted": -4.08,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesissued": "null",
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 2187000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": -1000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 231,
    "stockissuedduringperiodvaluenewissues": 25000000,
    "stockissuedduringperiodsharesnewissues": "null",
    "sharesissuedonexerciseofwarrantsvalue": 338000,
    "sharesissuedonexerciseofwarrants": 50834,
    "profitloss": -33152000,
    "depreciation": 27000,
    "adjustmentforamortization": 223000,
    "sharebasedcompensation": 1502000,
    "sharesissuedassettlementwithtradevendorasnonmonetarytransaction": 41000,
    "increasedecreaseingrantsreceivable": 153000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 228000,
    "increasedecreaseinaccountspayabletrade": 509000,
    "increasedecreaseinotheraccruedliabilities": -245000,
    "increasedecreaseinaccruedclinicalliabilities": 899000,
    "increasedecreaseinemployeerelatedliabilities": 466000,
    "increasedecreaseinleaseobligations": 14000,
    "netcashprovidedbyusedinoperatingactivities": -29440000,
    "proceedsfromwarrantexercises": 27450,
    "proceedsfromissuanceofcommonstock": 21343000,
    "proceedsfromconvertibledebt": 14929000,
    "netcashprovidedbyusedinfinancingactivities": 36610000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": -1000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 7169000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 43072000,
    "workingcapitalbalance": 40000000,
    "maturityperiodofhighlyliquidinvestmentstobeconsideredascashequivalent": "three months",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "three years",
    "numberofoperatingsegments": 1,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2019",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "propertyplantandequipmentusefullife": "P10Y",
    "propertyplantandequipmentestimatedusefullives": "Over the term of the lease",
    "maturityperiodofsecurities": "one year",
    "averageperiodtomaturityforportfolioofcashandmarketablesecurities": "P0D",
    "researchanddevelopmentexpensesincreasedecrease": -300000,
    "amortizationofintangibleassets": 200000,
    "finitelivedintangibleassetsgross": 3117000,
    "finitelivedintangibleassetsaccumulatedamortization": 1476000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 223000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 223000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 749000,
    "assetsfairvaluedisclosure": 41909000,
    "cashequivalentsatcarryingvalue": 41859000,
    "restrictedcashandcashequivalents": 50000,
    "debtinstrumentfaceamount": 15000000,
    "convertibledebt": 14920000,
    "convertibledebtfairvaluedisclosures": 15204000,
    "propertyplantandequipmentgross": 302000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 287000,
    "propertyplantandequipmentnet": 15000,
    "deferredfinancecostsnet": 109000,
    "interestpayablecurrentandnoncurrent": 29000,
    "futureincometaxrateassumedfordeferredtaxcalculations": 0.21,
    "deferredtaxassetsliabilitiesvaluationallowance": 55500000,
    "valuationallowancedeferredtaxassetchangeinamount": 7500000,
    "operatinglosscarryforwards": 3500,
    "operatinglosscarryforwardsexpirationyear": 2021,
    "operatinglosscarryforwardsindefinitely": 37300000,
    "taxcreditcarryforwardamount": 2700,
    "taxcreditcarryforwardexpirationyear": 2041,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "noncapitalgainlosscarryforwardsamount": 109500,
    "unclaimedtaxdeductionsrelatedtoscientificresearchandexperimentaldevelopmentexpenditures": 16000,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 800000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -31411000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -1741000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -33152000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -6962000,
    "incometaxreconciliationnondeductibleexpense": 224000,
    "incometaxreconciliationchangeinenactedtaxrate": 17000,
    "incometaxreconciliationforeignincometaxratedifferential": -77000,
    "incometaxreconciliationtaxcreditsinvestment": 134000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 7544000,
    "incometaxreconciliationreassessmentofpreviouslyrecognizednetoperatinglosses": -620000,
    "incometaxreconciliationotheradjustments": 8000,
    "deferredtaxassetspropertyplantandequipment": 897000,
    "deferredtaxassetsoperatinglosscarryforwards": 39356000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 7058000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 7159000,
    "deferredtaxassetsother": 1018000,
    "deferredtaxassetsgross": 55488000,
    "deferredtaxassetsvaluationallowance": 55082000,
    "deferredtaxassetsnet": 406000,
    "deferredtaxliabilitiesother": 406000,
    "deferredincometaxliabilities": 406000,
    "unrecognizedtaxbenefits": 761000,
    "unrecognizedtaxbenefitsincreasesdecreaseresultingfrompriorperiodtaxpositions": 6000,
    "opentaxyear": 2021,
    "preferredstocksharesauthorized": "null",
    "saleofstockdescriptionoftransaction": "Unit consisting of (a) one share of our common stock and (b) one warrant to purchase one-quarter of a share of common stock at an exercise price of $699.20 per share, or Warrant.  Each Warrant became exercisable six months following the issuance date until the date that is five years and six months after the issuance date and is subject to customary adjustments.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 7.32,
    "purchaseagreementexpireddate": "March 14, 2022",
    "stockunitsdescription": "Each Class B Unit consisted of one share of Series B Convertible Preferred Stock, par value $0.001 per share, convertible at any time at the holder’s option into 83 shares of common stock, and warrants to purchase 83 shares of common stock. ",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 3750,
    "numberofrequiredconsecutivedaysweightedaveragetradingpriceforcancelationorrecallofwarrants": "P30D",
    "grossproceedsfromsaleofwarrantsandunits": 13800000,
    "warrantandunitsofferingcostincludingunderwritingdiscountsandcommissions": 1500000,
    "netproceedsfromsaleofwarrantsandunits": 12300000,
    "conversionofstocksharesconverted1": 6256,
    "conversionofstocksharesissued1": 521124,
    "percentageofexercisepriceexceedsinmeasurementperiod": 3,
    "averagedailytradingvolumeformeasurementperiod": 500000,
    "commonstocksharesavailableforfuturegrant": 25000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 229,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 522090,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnonoptionequityinstrumentsoutstandingnumber": 53250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 294650,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.96,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 3400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 1.49,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 19500,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.006600000000000001,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.101,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 26.11,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 12.07,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 39204,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 67.51,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 28952,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 522090,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 26.11,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P8Y8M19D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 84822,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 98.12,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P7Y5M1D",
    "allocatedsharebasedcompensationexpense": 400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 53250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 53250,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 231,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 13.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 13.09,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 580,
    "classofwarrantorrightoutstanding": 50000,
    "classofwarrantsorrightexpirationdate": "December 2025",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1800000,
    "contractualobligation": 74000,
    "contractualobligationdueinnexttwelvemonths": 51000,
    "contractualobligationdueinsecondandthirdyear": 23000,
    "expirationofoperatingleaseagreement": "January 2019",
    "lesseeoperatingleasedescription": "On December 11, 2017, we entered into a lease, or the Seattle Lease, with 520 Pike Street, Inc., or Pike, pursuant to which we leased approximately 3,187 square feet located at Suite 2250 at 520 Pike Tower, Seattle, Washington, 98101, which commenced on March 1, 2018. The Seattle Lease expired on March 1, 2021 and was not renewed.",
    "operatingleaseexpense": 100000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 68000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 6000,
    "lesseeoperatingleaseliabilitypaymentsdue": 74000,
    "operatingleasepayments": 83000,
    "operatingleaseweightedaverageremainingleaseterm1": 1.08,
    "operatingleaseweightedaveragediscountratepercent": 0.09970000000000001
  },
  {
    "date": "2020-12-30",
    "symbol": "ACHV",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "tradingsymbol": "ACHV",
    "entityincorporationstatecountrycode": "DE",
    "entityregistrantname": "Achieve Life Sciences, Inc.",
    "entitycentralindexkey": 949858,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "033-80623",
    "entitytaxidentificationnumber": "95-4343413",
    "entityaddressaddressline1": "1040 West Georgia Street",
    "entityaddressaddressline2": "Suite 1030",
    "entityaddresscityortown": "Vancouver",
    "entityaddressstateorprovince": "BC",
    "entityaddresspostalzipcode": "V6E 4H1",
    "cityareacode": 604,
    "localphonenumber": "210-2217",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "icfrauditorattestationflag": "true",
    "cashandcashequivalentsatcarryingvalue": 35853000,
    "prepaidexpenseandotherassetscurrent": 1122000,
    "assetscurrent": 36975000,
    "restrictedcashandcashequivalentsnoncurrent": 50000,
    "propertyplantandequipmentnet": 11000,
    "operatingleaserightofuseasset": 146000,
    "otherassetsnoncurrent": 187000,
    "finitelivedintangibleassetsnet": 1864000,
    "goodwill": 1034000,
    "assets": 40298000,
    "accountspayablecurrent": 332000,
    "otheraccruedliabilitiescurrent": 584000,
    "accruedliabilitiesclinicalcurrent": 453000,
    "employeerelatedliabilitiescurrent": 1474000,
    "operatingleaseliabilitycurrent": 92000,
    "liabilitiescurrent": 2935000,
    "operatingleaseliabilitynoncurrent": 77000,
    "liabilities": 3012000,
    "commonstockvalue": 76000,
    "additionalpaidincapitalcommonstock": 97640000,
    "retainedearningsaccumulateddeficit": -60434000,
    "accumulatedothercomprehensiveincomelossnetoftax": 4000,
    "stockholdersequity": -60434000,
    "liabilitiesandstockholdersequity": 40298000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesdesignated": 6256,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 6111735,
    "commonstocksharesoutstanding": 6111735,
    "researchanddevelopmentexpense": 6882000,
    "generalandadministrativeexpense": 7868000,
    "costsandexpenses": 14750000,
    "investmentincomeinterest": 69000,
    "othernonoperatingincomeexpense": -49000,
    "nonoperatingincomeexpense": 20000,
    "netincomeloss": -14730000,
    "earningspersharebasicanddiluted": -5.42,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 2718909,
    "sharesissued": 6111735,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1286000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 236,
    "stockissuedduringperiodsharesreversestocksplits": -9,
    "stockissuedduringperiodvaluenewissues": 15789000,
    "stockissuedduringperiodsharesnewissues": 2472500,
    "stockissuedduringperiodvaluepreferredshareconversion": -2000,
    "stockissuedduringperiodsharespreferredshareconversion": -1121,
    "sharesissuedonexerciseofwarrantsvalue": 3231000,
    "sharesissuedonexerciseofwarrants": 489947,
    "adjustmentstoadditionalpaidincapitalsadditionalcoststofinancingschargedtoapic": -34000,
    "profitloss": -14730000,
    "depreciation": 32000,
    "adjustmentforamortization": 223000,
    "sharebasedcompensation": 883000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 452000,
    "increasedecreaseinaccountspayabletrade": -527000,
    "increasedecreaseinotheraccruedliabilities": 280000,
    "increasedecreaseinaccruedclinicalliabilities": 66000,
    "increasedecreaseinemployeerelatedliabilities": 358000,
    "increasedecreaseinleaseobligations": 10000,
    "netcashprovidedbyusedinoperatingactivities": -13474000,
    "proceedsfromissuanceofprivateplacement": 5307000,
    "paymentsofstockissuancecosts": 34000,
    "proceedsfromwarrantexercises": 3200000,
    "proceedsfromissuanceofcommonstock": 15789000,
    "netcashprovidedbyusedinfinancingactivities": 32680000,
    "paymentstoacquirepropertyplantandequipment": 17000,
    "netcashprovidedbyusedininvestingactivities": -17000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 19189000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 35903000,
    "workingcapitalbalance": 34000000,
    "maturityperiodofhighlyliquidinvestmentstobeconsideredascashequivalent": "P3M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "numberofoperatingsegments": 1,
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2019-01-01",
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "propertyplantandequipmentusefullife": "P10Y",
    "propertyplantandequipmentestimatedusefullives": "Over the term of the lease",
    "maturityperiodofsecurities": "P1Y",
    "averageperiodtomaturityforportfolioofcashandmarketablesecurities": "P0D",
    "amortizationofintangibleassets": 200000,
    "finitelivedintangibleassetsgross": 3117000,
    "finitelivedintangibleassetsaccumulatedamortization": 1253000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 223000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 223000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 972000,
    "assetsfairvaluedisclosure": 35903000,
    "cash": 473000,
    "cashequivalentsatcarryingvalue": 35380000,
    "restrictedcashandcashequivalents": 50000,
    "propertyplantandequipmentgross": 674000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 632000,
    "periodofnotutilizingdeferredshareissuancecostsandprepaidamountsrelatedtoinsurance": "P12M",
    "futureincometaxrateassumedfordeferredtaxcalculations": 0.21,
    "taxcreditcarryforwardamount": 300000,
    "operatinglosscarryforwards": 531000,
    "unclaimedtaxdeductionsrelatedtoscientificresearchandexperimentaldevelopmentexpenditures": 16000000,
    "taxcreditcarryforwardexpirationyear": 2040,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 800000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -3094000,
    "incometaxreconciliationnondeductibleexpense": 118000,
    "incometaxreconciliationchangeinenactedtaxrate": 34000,
    "incometaxreconciliationforeignincometaxratedifferential": -103000,
    "incometaxreconciliationtaxcreditsinvestment": 23000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 3662000,
    "incometaxreconciliationbooktotaxreturnadjustments": -518000,
    "incometaxreconciliationotheradjustments": -76000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "noncapitalgainlosscarryforwardsamount": 105596000,
    "deferredtaxassetspropertyplantandequipment": 892000,
    "deferredtaxassetsoperatinglosscarryforwards": 35596000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 7010000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 466000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 3757000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 164000,
    "deferredtaxassetsother": 183000,
    "deferredtaxassetsgross": 48068000,
    "deferredtaxassetsvaluationallowance": 47539000,
    "deferredtaxassetsnet": 529000,
    "deferredtaxliabilitiesrightofuseassets": 135000,
    "deferredtaxliabilitiesother": 394000,
    "deferredincometaxliabilities": 529000,
    "unrecognizedtaxbenefits": 767000,
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 5000,
    "unrecognizedtaxbenefitsincreasesresultingfromsettlementswithtaxingauthorities": 38000,
    "opentaxyear": 2020,
    "preferredstocksharesauthorized": 5000000,
    "saleofstockdescriptionoftransaction": "Unit consisting of (a) one share of our common stock and (b) one warrant to purchase one-quarter of a share of common stock at an exercise price of $699.20 per share, or Warrant.  Each Warrant became exercisable six months following the issuance date until the date that is five years and six months after the issuance date and is subject to customary adjustments.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 8.75,
    "stockunitsdescription": "Each Class B Unit consisted of one share of Series B Convertible Preferred Stock, par value $0.001 per share, convertible at any time at the holder’s option into 83 shares of common stock, and warrants to purchase 83 shares of common stock.",
    "classofwarrantorrightnumberofsecuritiescalledbywarrantsorrights": 489952,
    "numberofrequiredconsecutivedaysweightedaveragetradingpriceforcancelationorrecallofwarrants": "P30D",
    "grossproceedsfromsaleofwarrantsandunits": 13800000,
    "warrantandunitsofferingcostincludingunderwritingdiscountsandcommissions": 1500000,
    "netproceedsfromsaleofwarrantsandunits": 12300000,
    "conversionofstocksharesconverted1": 6256,
    "conversionofstocksharesissued1": 521124,
    "percentageofexercisepriceexceedsinmeasurementperiod": 3,
    "averagedailytradingvolumeformeasurementperiod": 500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 462,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 227442,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 231,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 8.76,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 2200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P6M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0094,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 1.0878,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 178380,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexpirationsinperiod": 30,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1406,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 44.64,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 10.66,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexpirationsinperiodweightedaverageexerciseprice": 34874.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 227.61,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 6424.01,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 39204,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 227442,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 44.64,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P9Y1M17D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 31814,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 221.96,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P7Y7M24D",
    "allocatedsharebasedcompensationexpense": 100000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 236,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 580,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 579.96,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 578,
    "classofwarrantorrightoutstanding": 50000,
    "classofwarrantsorrightexpirationdate": "2025-12",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1500000,
    "contractualobligation": 167000,
    "contractualobligationdueinnexttwelvemonths": 93000,
    "contractualobligationdueinsecondandthirdyear": 74000,
    "expirationofoperatingleaseagreement": "2019-01",
    "descriptionoflesseeleasingarrangementsoperatingleases": "On December 11, 2017, we entered into a lease, or the Seattle Lease, with 520 Pike Street, Inc., or Pike, pursuant to which we leased approximately 3,187 square feet located at Suite 2250 at 520 Pike Tower, Seattle, Washington, 98101, which commenced on March 1, 2018. The initial term of the Seattle Lease expired at the end of the February 2021 on the third anniversary of the Seattle Lease. This lease was not renewed.",
    "percentageprofitattributabletolessor": 0.5,
    "propertysubleasepercentageterminationeligibility": 0.5,
    "operatingleaseexpense": 200000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 25000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 68000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 6000,
    "lesseeoperatingleaseliabilitypaymentsdue": 25000,
    "operatingleasepayments": 186000,
    "operatingleaseweightedaverageremainingleaseterm1": "P1Y9M7D",
    "operatingleaseweightedaveragediscountratepercent": 0.0997
  },
  {
    "date": "2019-12-30",
    "symbol": "ACHV",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "tradingsymbol": "ACHV",
    "entityincorporationstatecountrycode": "DE",
    "entityregistrantname": "Achieve Life Sciences, Inc.",
    "entitycentralindexkey": 949858,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entityshellcompany": "false",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityfilenumber": "033-80623",
    "entitytaxidentificationnumber": "95-4343413",
    "entityaddressaddressline1": "1040 West Georgia Street",
    "entityaddressaddressline2": "Suite 1030",
    "entityaddresscityortown": "Vancouver",
    "entityaddressstateorprovince": "BC",
    "entityaddresspostalzipcode": "V6E 4H1",
    "cityareacode": 604,
    "localphonenumber": "210-2217",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "cashandcashequivalentsatcarryingvalue": 16664000,
    "accountsreceivablenetcurrent": 8000,
    "prepaidexpensecurrent": 662000,
    "assetscurrent": 17334000,
    "restrictedcashandcashequivalentsnoncurrent": 50000,
    "propertyplantandequipmentnet": 5000,
    "operatingleaserightofuseasset": 329000,
    "otherassetsnoncurrent": 187000,
    "finitelivedintangibleassetsnet": 2087000,
    "goodwill": 1034000,
    "assets": 21078000,
    "accountspayablecurrent": 859000,
    "otheraccruedliabilitiescurrent": 304000,
    "accruedliabilitiesclinicalcurrent": 387000,
    "employeerelatedliabilitiescurrent": 1116000,
    "operatingleaseliabilitycurrent": 203000,
    "liabilitiescurrent": 2869000,
    "operatingleaseliabilitynoncurrent": 159000,
    "liabilities": 3028000,
    "commonstockvalue": 41000,
    "additionalpaidincapitalcommonstock": 63709000,
    "retainedearningsaccumulateddeficit": -45704000,
    "accumulatedothercomprehensiveincomelossnetoftax": 4000,
    "stockholdersequity": -45704000,
    "liabilitiesandstockholdersequity": 21078000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesdesignated": 6256,
    "preferredstocksharesissued": 1121,
    "preferredstocksharesoutstanding": 1121,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 29485178,
    "commonstocksharesoutstanding": 29485178,
    "researchanddevelopmentexpense": 9674000,
    "generalandadministrativeexpense": 6854000,
    "costsandexpenses": 16528000,
    "investmentincomeinterest": 170000,
    "othernonoperatingincomeexpense": -37000,
    "nonoperatingincomeexpense": 133000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -16395000,
    "netincomeloss": -16395000,
    "comprehensiveincomenetoftax": -16395000,
    "earningspersharebasicanddiluted": -1.99,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 8246400,
    "sharesissued": 1121,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1201000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 5134,
    "adjustmentstoadditionalpaidincapitalstockissuedissuancecosts": 116000,
    "cumulativeeffectonretainedearningsnetoftax1": -3000,
    "stockissuedduringperiodvaluenewissues": 12334000,
    "stockissuedduringperiodsharesnewissues": 374000,
    "stockissuedduringperiodvaluewarrantsexercised": 4199000,
    "stockissuedduringperiodshareswarrantsexercised": 1107813,
    "stockissuedduringperiodvaluepreferredshareconversion": -9000,
    "stockissuedduringperiodsharespreferredshareconversion": -5135,
    "adjustmentstoadditionalpaidincapitalwarrantissued": -3925000,
    "profitloss": -16395000,
    "depreciation": 31000,
    "adjustmentforamortization": 223000,
    "sharebasedcompensation": 837000,
    "newaccountingpronouncementorchangeinaccountingprincipleeffectofadoptionquantification": 3000,
    "increasedecreaseinaccountsreceivable": 1000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -195000,
    "increasedecreaseinaccountspayabletrade": 715000,
    "increasedecreaseinotheraccruedliabilities": -328000,
    "increasedecreaseinaccruedclinicalliabilities": -812000,
    "increasedecreaseinemployeerelatedliabilitiesexcludingaccruedsalaries": -52000,
    "increasedecreaseinleaseobligations": -10000,
    "netcashprovidedbyusedinoperatingactivities": -15216000,
    "proceedsfromissuanceofprivateplacement": 792000,
    "proceedsfrompublicoffering": 12334000,
    "proceedsfromwarrantexercises": 800000,
    "netcashprovidedbyusedinfinancingactivities": 17325000,
    "paymentstoacquirepropertyplantandequipment": 53000,
    "paymentstoacquireinvestments": 25000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 5114000,
    "netcashprovidedbyusedininvestingactivities": 5036000,
    "effectofexchangerateoncashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 4000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 7149000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 16714000,
    "typeofrevenueextensiblelist": "us-gaap:ProductMember",
    "cashcashequivalentsandshortterminvestments": 16700000,
    "workingcapitalbalance": 14500000,
    "businessacquisitionsproformanetincomeloss": -16395000,
    "businessacquisitionproformaearningspersharebasicanddiluted": -1.99,
    "businessacquisitionproformaweightedaverageshares": 8246400,
    "maturityperiodofhighlyliquidinvestmentstobeconsideredascashequivalent": "P3M",
    "descriptionofmaturityperiodoffinancialinstrumentstobeconsideredasshortterminvestment": "Greater than three months and less than one year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P10Y",
    "propertyplantandequipmentestimatedusefullives": "Over the term of the lease",
    "maturityperiodofsecurities": "P1Y",
    "averageperiodtomaturityforportfolioofcashandmarketablesecurities": "P0D",
    "amortizationofintangibleassets": 200000,
    "finitelivedintangibleassetsgross": 3117000,
    "finitelivedintangibleassetsaccumulatedamortization": 1030000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 223000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 223000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 1195000,
    "maximummaturityperiodofcashandcashequivalents": "P90D",
    "maximummaturityperiodofshortterminvestments": "P1Y",
    "assetsfairvaluedisclosure": 16714000,
    "cash": 949000,
    "cashequivalentsatcarryingvalue": 15715000,
    "restrictedcashandcashequivalents": 50000,
    "propertyplantandequipmentgross": 657000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 600000,
    "periodofnotutilizingdeferredshareissuancecostsandprepaidamountsrelatedtoinsurance": "P12M",
    "futureincometaxrateassumedfordeferredtaxcalculations": 0.21,
    "taxcreditcarryforwardamount": 200000,
    "operatinglosscarryforwards": 1048000,
    "unclaimedtaxdeductionsrelatedtoscientificresearchandexperimentaldevelopmentexpenditures": 15500000,
    "taxcreditcarryforwardexpirationyear": 2039,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 700000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -3490000,
    "incometaxreconciliationnondeductibleexpense": 116000,
    "incometaxreconciliationchangeinenactedtaxrate": -13000,
    "incometaxreconciliationforeignincometaxratedifferential": -296000,
    "incometaxreconciliationtaxcreditsinvestment": 84000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": -3246000,
    "incometaxreconciliationbooktotaxreturnadjustments": -75000,
    "incometaxreconciliationunrecognizedtaxbenefits": 7192000,
    "incometaxreconciliationprioryearincometaxes": -221000,
    "incometaxreconciliationotheradjustments": -104000,
    "incometaxexpensebenefitexcludingadjustmentforreversalofdeferredtaxliability": -221000,
    "noncapitalgainlosscarryforwardsamount": 104213000,
    "deferredtaxassetspropertyplantandequipment": 891000,
    "deferredtaxassetsoperatinglosscarryforwards": 33166000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 6256000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 315000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 3501000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 79000,
    "deferredtaxassetsother": 181000,
    "deferredtaxassetsgross": 44389000,
    "deferredtaxassetsvaluationallowance": 43875000,
    "deferredtaxassetsnet": 514000,
    "deferredtaxliabilitiesrightofuseassets": 79000,
    "deferredtaxliabilitiesother": 435000,
    "deferredincometaxliabilities": 514000,
    "unrecognizedtaxbenefits": 724000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 7000,
    "opentaxyear": 2019,
    "preferredstocksharesauthorized": 5000000,
    "saleofstockdescriptionoftransaction": "Unit consisting of (a) one share of our common stock and (b) one warrant to purchase one-quarter of a share of common stock at an exercise price of $34.96 per share, or Warrant.  Each Warrant became exercisable six months following the issuance date until the date that is five years and six months after the issuance date and is subject to customary adjustments.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 0.6,
    "proceedsfromissuanceofcommonstockgross": 800000,
    "stockunitsdescription": "Each Class B Unit consisted of one share of Series B Convertible Preferred Stock, par value $0.001 per share, convertible at any time at the holder’s option into 1,666 shares of common stock, and warrants to purchase 1,666 shares of common stock.",
    "grossproceedsfromsaleofwarrantsandunits": 13800000,
    "warrantandunitsofferingcostincludingunderwritingdiscountsandcommissions": 1500000,
    "netproceedsfromsaleofwarrantsandunits": 12300000,
    "conversionofstocksharesconverted1": 5135,
    "conversionofstocksharesissued1": 8554910,
    "commonstocksharesavailableforfuturegrant": 6000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 15931,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1010583,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 10008,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 1.33,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 1800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y6M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0252,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.9425,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 345350,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 352,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 10.05,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 1.73,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 2450.8,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 1348.06,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 1960.2,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 1010583,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 10.05,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P8Y8M8D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 325379,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 22.93,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P8Y5M4D",
    "allocatedsharebasedcompensationexpense": 400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 5134,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 28.99,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 33.54,
    "numberofwarrantsexercised": 270313,
    "classofwarrantorrightoutstanding": 23000000,
    "classofwarrantsorrightexpirationdate": "2024-12",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 28100000,
    "relatedpartytransactiondate": "2017-08-01",
    "contractualobligation": 377000,
    "contractualobligationdueinnexttwelvemonths": 213000,
    "contractualobligationdueinsecondandthirdyear": 158000,
    "contractualobligationdueinfourthandfifthyear": 6000,
    "expirationofoperatingleaseagreement": "2019-01",
    "leaseexpirationdate1": "2018-03-31",
    "descriptionoflesseeleasingarrangementsoperatingleases": "On December 11, 2017, we entered into a lease, or the New Lease, with 520 Pike Street, Inc., or Pike, pursuant to which we leased approximately 3,187 square feet located at Suite 2250 at 520 Pike Tower, Seattle, Washington, 98101, which commenced on March 1, 2018. The initial term of the New Lease will expire at the end of the month on the third anniversary of the New Lease.",
    "percentageprofitattributabletolessor": 0.5,
    "propertysubleasepercentageterminationeligibility": 0.5,
    "operatingleasesrentexpensenet": 200000,
    "operatingleasesfutureminimumpaymentsduecurrent": 148000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 25000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 67000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 6000,
    "operatingleasesfutureminimumpaymentsdue": 173000,
    "operatingleasepayments": 176000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 455000,
    "operatingleaseweightedaverageremainingleaseterm1": "P2Y1M28D",
    "operatingleaseweightedaveragediscountratepercent": 0.0997
  },
  {
    "date": "2018-12-30",
    "symbol": "ACHV",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2018-12-31",
    "documentfiscalyearfocus": 2018,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ACHV",
    "entityregistrantname": "ACHIEVE LIFE SCIENCES, INC.",
    "entitycentralindexkey": 949858,
    "currentfiscalyearenddate": "--12-31",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "cashandcashequivalentsatcarryingvalue": 9515000,
    "shortterminvestments": 5089000,
    "accountsreceivablenetcurrent": 7000,
    "prepaidexpensecurrent": 926000,
    "assetscurrent": 15537000,
    "restrictedcashandcashequivalentsnoncurrent": 50000,
    "propertyplantandequipmentnet": 5000,
    "otherassetsnoncurrent": 118000,
    "finitelivedintangibleassetsnet": 2310000,
    "goodwill": 1034000,
    "assets": 19084000,
    "accountspayablecurrent": 144000,
    "otheraccruedliabilitiescurrent": 748000,
    "accruedliabilitiesclinicalcurrent": 1199000,
    "employeerelatedliabilitiescurrent": 1168000,
    "capitalleaseobligationscurrent": 11000,
    "liabilitiescurrent": 3270000,
    "capitalleaseobligationsnoncurrent": 12000,
    "liabilities": 3282000,
    "commonstockvalue": 18000,
    "additionalpaidincapitalcommonstock": 41161000,
    "retainedearningsaccumulateddeficit": -25381000,
    "accumulatedothercomprehensiveincomelossnetoftax": 4000,
    "stockholdersequity": -25381000,
    "liabilitiesandstockholdersequity": 19084000,
    "preferredstockparorstatedvaluepershare": 0.001,
    "preferredstocksharesauthorized": 5000000,
    "preferredstocksharesissued": 579,
    "preferredstocksharesoutstanding": 579,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 150000000,
    "commonstocksharesissued": 6721117,
    "commonstocksharesoutstanding": 6721117,
    "researchanddevelopmentexpense": 5868000,
    "generalandadministrativeexpense": 6945000,
    "costsandexpenses": 12813000,
    "investmentincomeinterest": 171000,
    "othernonoperatingincomeexpense": -45000,
    "nonoperatingincomeexpense": 126000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -12687000,
    "netincomeloss": -12687000,
    "othercomprehensiveincomelossnetoftax": -1000,
    "comprehensiveincomenetoftax": -12687000,
    "earningspersharebasicanddiluted": -3.61,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 3510217,
    "sharesissued": 579,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 854000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 5354,
    "stockissuedduringperiodsharesreversestocksplits": -38,
    "stockissuedduringperiodvaluenewissues": 4960000,
    "stockissuedduringperiodsharesnewissues": 1789258,
    "stockissuedduringperiodvaluewarrantsexercised": 1324000,
    "stockissuedduringperiodshareswarrantsexercised": 330500,
    "stockissuedduringperiodvaluepreferredshareconversion": -2000,
    "stockissuedduringperiodsharespreferredshareconversion": -8579,
    "profitloss": -12687000,
    "depreciation": 60000,
    "adjustmentforamortization": 222000,
    "sharebasedcompensation": 582000,
    "increasedecreaseinaccountsreceivable": -2000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 343000,
    "increasedecreaseinaccountspayabletrade": -69000,
    "increasedecreaseinotheraccruedliabilities": 310000,
    "increasedecreaseinaccruedliabilities": 322000,
    "increasedecreaseinemployeerelatedliabilities": 710000,
    "increasedecreaseinleaseobligations": 4000,
    "netcashprovidedbyusedinoperatingactivities": -10623000,
    "proceedsfromissuanceorsaleofequity": 1279000,
    "proceedsfrompublicoffering": 12194000,
    "proceedsfromwarrantexercises": 1300000,
    "proceedsfromissuanceofprivateplacement": 4960000,
    "netcashprovidedbyusedinfinancingactivities": 19757000,
    "paymentstoacquirepropertyplantandequipment": 46000,
    "proceedsfromsaleofproductiveassets": 10000,
    "paymentstoacquireinvestments": 5539000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 450000,
    "netcashprovidedbyusedininvestingactivities": -5125000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 4009000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 9565000,
    "typeofrevenueextensiblelist": "us-gaap:ProductMember",
    "cashcashequivalentsandshortterminvestments": 14600000,
    "workingcapitalbalance": 12300000,
    "warrantsandrightsoutstandingmeasurementinput": 1.11,
    "warrantsandrightsoutstandingterm": "P6M",
    "businessacquisitionsproformanetincomeloss": -12687000,
    "businessacquisitionproformaearningspersharebasicanddiluted": -3.61,
    "businessacquisitionproformaweightedaverageshares": 3510217,
    "maturityperiodofhighlyliquidinvestmentstobeconsideredascashequivalent": "P3M",
    "descriptionofmaturityperiodoffinancialinstrumentstobeconsideredasshortterminvestment": "Greater than three months and less than one year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P3Y",
    "numberofoperatingsegments": 1,
    "propertyplantandequipmentusefullife": "P10Y",
    "propertyplantandequipmentestimatedusefullives": "Over the term of the lease",
    "maturityperiodofsecurities": "P1Y",
    "averageperiodtomaturityforportfolioofcashandmarketablesecurities": "P0D",
    "amortizationofintangibleassets": 200000,
    "finitelivedintangibleassetsgross": 3117000,
    "finitelivedintangibleassetsaccumulatedamortization": 807000,
    "finitelivedintangibleassetsamortizationexpensenexttwelvemonths": 223000,
    "finitelivedintangibleassetsamortizationexpenseyeartwo": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearthree": 223000,
    "finitelivedintangibleassetsamortizationexpenseyearfour": 223000,
    "finitelivedintangibleassetsamortizationexpenseafteryearfour": 1418000,
    "maximummaturityperiodofcashandcashequivalents": "P90D",
    "maximummaturityperiodofshortterminvestments": "P1Y",
    "assetsfairvaluedisclosure": 14654000,
    "cash": 1070000,
    "cashequivalentsatcarryingvalue": 8445000,
    "restrictedcashandcashequivalents": 50000,
    "propertyplantandequipmentgross": 755000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 720000,
    "periodofnotutilizingdeferredshareissuancecostsandprepaidamountsrelatedtoinsurance": "P12M",
    "futureincometaxrateassumedfordeferredtaxcalculations": 0.21,
    "taxcreditcarryforwardamount": 100000,
    "operatinglosscarryforwards": 887000,
    "unclaimedtaxdeductionsrelatedtoscientificresearchandexperimentaldevelopmentexpenditures": 14500000,
    "taxcreditcarryforwardexpirationyear": 2038,
    "unrecognizedtaxbenefitsthatwouldimpacteffectivetaxrate": 700000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -2664000,
    "incometaxreconciliationnondeductibleexpense": 70000,
    "incometaxreconciliationchangeinenactedtaxrate": -1416000,
    "incometaxreconciliationforeignincometaxratedifferential": -165000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 4182000,
    "incometaxreconciliationbooktotaxreturnadjustments": 20000,
    "incometaxreconciliationotheradjustments": -27000,
    "noncapitalgainlosscarryforwardsamount": 123295000,
    "deferredtaxassetspropertyplantandequipment": 886000,
    "deferredtaxassetsoperatinglosscarryforwards": 37332000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 5707000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 171000,
    "deferredtaxassetscapitalizedresearchanddevelopmentexpenses": 3334000,
    "deferredtaxassetsother": 170000,
    "deferredtaxassetsgross": 47600000,
    "deferredtaxassetsvaluationallowance": 47123000,
    "deferredtaxassetsnet": 477000,
    "deferredtaxliabilitiesgoodwillandintangibleassetsintangibleassets": 474000,
    "deferredtaxliabilitiesother": 3000,
    "deferredincometaxliabilities": 477000,
    "unrecognizedtaxbenefits": 717000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 6000,
    "unrecognizedtaxbenefitsdecreasesresultingfrompriorperiodtaxpositions": 4000,
    "opentaxyear": 2018,
    "saleofstockdescriptionoftransaction": "Unit consisting of (a) one share of our Common Stock and (b) one warrant to purchase one-quarter of a share of Common Stock at an exercise price of $34.96 per share, or Warrant.  Each Warrant is exercisable six months following the issuance date until the date that is five years and six months after the issuance date and is subject to customary adjustments.",
    "classofwarrantorrightexercisepriceofwarrantsorrights1": 3.14,
    "stockunitsdescription": "Each Class B Unit consisted of one share of Series A Convertible Preferred Stock par value $0.001 per share convertible at any time at the holder’s option into 250 shares of common stock and warrants to purchase 250 shares of common stock.",
    "grossproceedsfromsaleofwarrantsandunits": 13800000,
    "warrantandunitsofferingcostincludingunderwritingdiscountsandcommissions": 1600000,
    "netproceedsfromsaleofwarrantsandunits": 12200000,
    "conversionofstocksharesconverted1": 8579,
    "conversionofstocksharesissued1": 2144750,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 21065,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 665585,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 15142,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 2.05,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 2400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y6M29D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1000000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0293,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y8M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.8823,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 554400,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 393,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 15.65,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 2.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 160.79,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangelowerrangelimit": 1659.36,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeupperrangelimit": 2450.8,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofoutstandingoptions": 665585,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageexercisepricebeginningbalance1": 15.65,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeoutstandingoptionsweightedaverageremainingcontractualterm2": "P9Y5M15D",
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangenumberofexercisableoptions": 96615,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageexerciseprice1": 73.05,
    "sharebasedcompensationsharesauthorizedunderstockoptionplansexercisepricerangeexercisableoptionsweightedaverageremainingcontractualterm2": "P8Y11M8D",
    "allocatedsharebasedcompensationexpense": 200000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedsharebasedawardsotherthanoptions": 400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 5354,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 570,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 30.53,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 56.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 97.03,
    "classofwarrantorrightoutstanding": 894626,
    "classofwarrantsorrightexpirationdate": "2023-10",
    "numberofwarrantsexercised": 330500,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 4700000,
    "relatedpartytransactiondate": "2017-08-01",
    "contractualobligation": 574000,
    "contractualobligationdueinnexttwelvemonths": 207000,
    "contractualobligationdueinsecondandthirdyear": 298000,
    "contractualobligationdueinfourthandfifthyear": 69000,
    "expirationofoperatingleaseagreement": "2019-01",
    "leaseexpirationdate1": "2018-03-31",
    "descriptionoflesseeleasingarrangementsoperatingleases": "On December 11, 2017, we entered into a lease, or New Lease, with 520 Pike Street, Inc., or Pike, pursuant to which we leased approximately 3,187 square feet located at Suite 2250 at 520 Pike Tower, Seattle, Washington, 98101, which commenced on March 1, 2018. The initial term of the New Lease will expire at the end of the month on the third anniversary of the New Lease.",
    "percentageprofitattributabletolessor": 0.5,
    "propertysubleasepercentageterminationeligibility": 0.5,
    "operatingleasesrentexpensenet": 300000,
    "operatingleasesfutureminimumpaymentsduecurrent": 144000,
    "operatingleasesfutureminimumpaymentsdueintwoyears": 148000,
    "operatingleasesfutureminimumpaymentsdueinthreeyears": 25000,
    "operatingleasesfutureminimumpaymentsdueinfouryears": 63000,
    "operatingleasesfutureminimumpaymentsdueinfiveyears": 5000,
    "operatingleasesfutureminimumpaymentsdue": 317000
  }
]